Morepen Laboratories Limited has informed the Exchange about Intimation of incorporation of a step down subsidiary company - SIGMACHECK HEALTH PRIVATE LIMITED.
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Morepen Laboratories has incorporated a new step-down subsidiary named SIGMACHECK HEALTH PRIVATE LIMITED, which has been approved by the Ministry of Corporate Affairs on August 13, 2025. The new entity will operate in the medical devices sector and is a wholly owned subsidiary of Morepen Medipath Limited (formerly Morepen Medtech Limited), giving Morepen Laboratories an indirect 60% holding. It has been set up with a modest paid-up capital of ₹1 Lakh (10,000 equity shares of ₹10 each), entirely funded through cash by MML. The stated objective is to cater to the growing demand for medical devices.
This is a small, strategic step into the medical devices space with negligible capital outlay, so it is unlikely to move the stock in the near term. However, it signals the company's intent to expand its medical devices footprint, which investors may view as a positive long-term directional move.